Navigation Links
CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS

eutics. The Company owns three clinical-stage compounds based on its small molecule "molecular chaperone" co-induction technology. In September 2006, CytRx announced that arimoclomol was shown to be safe and well tolerated at all three doses tested in its Phase IIa clinical trial in patients with ALS. The Company plans to enter a Phase IIb clinical trial with arimoclomol in ALS in the second half of 2007, subject to FDA clearance. Based on preliminary discussions with the FDA, CytRx is now considering a second efficacy clinical trial for ALS, possibly in parallel with the upcoming Phase IIb trial, to provide additional efficacy data to support a possible approval decision by the FDA.

The FDA has granted Fast Track designation and Orphan Drug status to arimoclomol for the treatment of ALS, which has also been granted orphan medicinal product status for the treatment of ALS by the European Commission. The Company has announced plans to commence a Phase II clinical trial for arimoclomol in stroke recovery in the first half of 2008, subject to FDA clearance. The Company has also announced plans to commence a Phase II clinical trial with its next drug candidate, iroxanadine, for diabetic foot ulcers in the first half of 2008, subject to FDA clearance. In addition, the Company plans to open a research and development facility in San Diego in the third quarter of 2007. For more information on the Company, visit www.cytrx.com.

About RXi Pharmaceuticals Corporation

Worcester, Massachusetts-based RXi Pharmaceuticals Corporation, a majority-owned subsidiary of CytRx, is a biopharmaceutical research and development company that focuses on developing RNAi-based therapeutics for the treatment of human disease. RXi's initial focus is on neurodegenerative diseases, oncology, type 2 diabetes and obesity. RXi has licenses to a diverse series of early patents and patent applications that were filed from 1998 to 2006 in the areas of RNAi target sequences, RNAi chem
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
2. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
6. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
7. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
11. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
Post Your Comments:
(Date:5/26/2015)... ATLANTA , May 26, 2015  EndoChoice today ... 6,250,000 shares of its common stock, which will represent ... into a Delaware corporation in ... is currently estimated to be between $15 and $17 ... have a 30-day option to purchase up to an ...
(Date:5/26/2015)... 26, 2015 Cellular testing ... ,What,s the future of technologies for screening cells? ... 2015. Stay ahead there for data, benefiting your ... results, R&D, opportunities and revenue forecasts. ... you what,s possible for cell-based assays ...
(Date:5/26/2015)... 2015  Array BioPharma Inc. (Nasdaq: ARRY ... Ron Squarer , will present at the ... City. The public is welcome to participate in the ... website.Event: Jefferies 2015 Global Healthcare ConferencePresenter:Ron Squarer, Chief ... Webcast: www.arraybiopharma.com  About Array BioPharma Array BioPharma ...
Breaking Medicine Technology:EndoChoice Announces Launch of Its Initial Public Offering 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7
... MORRISVILLE, N.C., Sept. 11 Clinical Logistics is pleased to announce ... Corporation (Gentris), a GLP compliant laboratory, located in Morrisville, North Carolina. ... DNA, RNA, whole blood, FFPE tissue blocks, urine, plasma, serum, saliva, ... storage conditions is available: , , ...
... YORK, Sept. 11 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova ... method for destroying breast cancer cells, using stem cell ... that enables us to identify the protein expression in ... tumors. This ability to identify the molecular markers of ...
Cached Medicine Technology:Clinical Logistics Enters Partnership with Gentris Corporation 2New stem cell identification technology could cure breast cancer 2
(Date:5/26/2015)... Nagpur, India (PRWEB) May 26, 2015 ... April 2015, one of the leading online health and ... an impact to the online community. It has ... for people to read articles, watch videos, ask questions ... , The launch of the official Consumer Health Digest ...
(Date:5/26/2015)... Abington is pleased to announce that ... with seven medical professionals, has joined Abington Health ... in the United States to be recognized as ... National Committee for Quality Assurance. , Family Medicine, ... care – including routine gynecology care and minor ...
(Date:5/26/2015)... 3,000 senior industry executives are expected at the ... of the connected car. A very special attraction for ... read a driver’s brain waves. Visitors to its booth ... mind alone just by gripping the steering wheel! , ... working on cognitive load, altering music based on the ...
(Date:5/26/2015)... 26, 2015 It was an evening ... in Colorado. On Wednesday, May 13, The Denver Foundation ... new era of community-based giving with its Annual Celebration, ... in the Making,” the event celebrated the donors, leaders, ... to mobilize resources for good. , “If your organization, ...
(Date:5/26/2015)... 26, 2015 On May 26, 2015, My ... salesman and distributor Dwayne Windfall. At the start of the ... that has some unique characteristics with it, so could you ... Windfall replies saying, “I was reading the newspaper looking for ... they were looking for a person with hustle. I responded ...
Breaking Medicine News(10 mins):Health News:Consumer Health Digest Official YouTube Channel: A Reliable Source of Health Information 2Health News:Family Medicine, Geriatrics and Wellness Joins Abington Health Physicians 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2
... A childs innocence and vulnerability presents a target for ... are beginning to understand the communication process by which ... information could better equip parents and community members to ... sexual abuse. , Our children are our greatest gift ...
... April 17 LodgeNet,Interactive Corporation (Nasdaq: LNET ... been appointed to its Board of Directors. LodgeNet ... designed to meet,the unique needs of hospitality, healthcare ... Mr. Haire spent more than 25 years ...
... listed on the menu or not, the American Diabetes Association,provides ... Pop quiz -- which,has more calories -- a tuna ... surprised to learn the tuna fish salad normally has at ... for your daily diet?,And how many calories a day are ...
... for circulating viruses, CDC says , , THURSDAY, April 17 (HealthDay ... worst in four years, due, in part, to a vaccine ... of flu virus, U.S. health officials said Thursday. , For ... during the 2007-08 season, the vaccine was 58 percent effective. ...
... Hospital is the only pediatric hospital in the ... The American Nurses,Credentialing Center (ANCC) has awarded DMC ... nursing. Recognized as one of the,highest distinctions a ... five,percent of all U.S. hospitals have achieved this ...
... Work could lead to better understanding of autoimmune diseases, ... Without using an egg, researchers have been able to ... a new report says. , A research team from ... B cells, immune cells that can bind to specific ...
Cached Medicine News:Health News:MU researchers reveal communication tactics used by sexual predators to entrap children 2Health News:LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors 2Health News:What You Don't Know Could Hurt You 2Health News:What You Don't Know Could Hurt You 3Health News:Current Flu Season Worst in 4 Years 2Health News:Current Flu Season Worst in 4 Years 3Health News:Children's Hospital of Michigan Awarded Prestigious Magnet Status 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: